The Use of Autologous Protein Solution (Pro-Stride^®) and Leukocyte-Rich Platelet-Rich Plasma (Restigen^®) in Canine Medicine

References

• Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001;10(4):225–228. doi:10.1097/00008505-200110000-00002
   PubMedGoogle Scholar
• Wehling P, Moser C, Frisbie D, et al. Autologous conditioned serum in the treatment of orthopedic diseases. BioDrugs. 2007;21(5):323–332. doi:10.2165/00063030-200721050-00004
   PubMed Web of Science ®Google Scholar
• O’Shaughnessey K, Matuska A, Hoeppner J, et al. Autologous protein solution prepared from the blood of osteoarthritic patients contains an enhanced profile of anti-inflammatory cytokines and anabolic growth factors. J Orthop Res. 2014;32(10):1349–1355. doi:10.1002/jor.22671
   PubMed Web of Science ®Google Scholar
• Bosch G, van Schie HT, de Groot MW, et al. Effects of platelet-rich plasma on the quality of repair of mechanically induced core lesions in equine superficial digital flexor tendons: a placebo-controlled experimental study. J Orthop Res. 2010;28(2):211–217. doi:10.1002/jor.20980
   PubMed Web of Science ®Google Scholar
• Bosch G, Moleman M, Barneveld A, van Weeren PR, Van Schie H. The effect of platelet-rich plasma on the neovascularization of surgically created equine superficial digital flexor tendon lesions. Scand J Med Sci Sports. 2011;21(4):554–561. doi:10.1111/j.1600-0838.2009.01070.x
   PubMed Web of Science ®Google Scholar
• Ortved KF. Regenerative medicine and rehabilitation for tendinous and ligamentous injuries in sport horses. Vet Clin Eq Pract. 2018;34(2):359–373.
   PubMed Web of Science ®Google Scholar
• Ho LK, Baltzer WI, Nemanic S, Stieger-Vanegas SM. Single ultrasound-guided platelet-rich plasma injection for treatment of supraspinatus tendinopathy in dogs. Can Vet J. 2015;56(8):845–849.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Ueda M, Naiki T, Takahashi M, Hata K-I, Nagasaka T. Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: tissue-engineered bone regeneration. Tissue Eng. 2004;10(5–6):955–964. doi:10.1089/1076327041348284
   PubMedGoogle Scholar
• Kim S-G, Chung C-H, Kim Y-K, Park J-C, Lim S-C. Use of particulate dentin–plaster of paris combination with/without platelet-rich plasma in the treatment of bone defects around implants. Int J Oral Maxillofac Implants. 2002;17(1):86–94.
   PubMed Web of Science ®Google Scholar
• Suba Z, Takács D, Gyulai-Gaál S, Kovács K. Facilitation of β-tricalcium phosphate-induced alveolar bone regeneration by platelet-rich plasma in beagle dogs: a Histologic and Histomorphometric Study. Int J Oral Maxillofac Implants. 2004;19(6):832–838.
   PubMed Web of Science ®Google Scholar
• Frisbie DD, Kawcak CE, Werpy NM, Park RD, McIlwraith CW. Clinical, biochemical, and histologic effects of intra-articular administration of autologous conditioned serum in horses with experimentally induced osteoarthritis. Am J Vet Res. 2007;68(3):290–296. doi:10.2460/ajvr.68.3.290
   PubMed Web of Science ®Google Scholar
• Baltzer A, Moser C, Jansen S, Krauspe R. Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis. Osteoarthritis Cartilage. 2009;17(2):152–160. doi:10.1016/j.joca.2008.06.014
   PubMed Web of Science ®Google Scholar
• Sawyere DM, Lanz OI, Dahlgren LA, Barry SL, Nichols AC, Werre SR. Cytokine and growth factor concentrations in canine autologous conditioned serum. Vet Surg. 2016;45(5):582–586. doi:10.1111/vsu.12506
   PubMed Web of Science ®Google Scholar
• Smith RK. Regenerative medicine in equine orthopaedics: what and when? Vet Equine. 2020;4(1):8–13. doi:10.12968/ukve.2020.4.1.8
   Google Scholar
• Woodell-May J, Matuska A, Oyster M, Welch Z, O’shaughnessey K, Hoeppner J. Autologous protein solution inhibits MMP-13 production by IL-1β and TNFα-stimulated human articular chondrocytes. J Orthop Res. 2011;29(9):1320–1326. doi:10.1002/jor.21384
   PubMed Web of Science ®Google Scholar
• Matuska A, O’shaughnessey K, King W, Woodell-May J. Autologous solution protects bovine cartilage explants from IL-1α-and TNFα-induced cartilage degradation. J Orthop Res. 2013;31(12):1929–1935. doi:10.1002/jor.22464
   PubMed Web of Science ®Google Scholar
• O’Shaughnessey KM, Panitch A, Woodell-May JE. Blood-derived anti-inflammatory protein solution blocks the effect of IL-1β on human macrophages in vitro. Inflamm Res. 2011;60(10):929. doi:10.1007/s00011-011-0353-2
   PubMed Web of Science ®Google Scholar
• Wanstrath AW, Hettlich BF, Su L, et al. Evaluation of a single intra-articular injection of autologous protein solution for treatment of osteoarthritis in a canine population. Vet Surg. 2016;45(6):764–774. doi:10.1111/vsu.12512
   PubMed Web of Science ®Google Scholar
• Franklin SP, Garner BC, Cook JL. Characteristics of canine platelet-rich plasma prepared with five commercially available systems. Am J Vet Res. 2015;76(9):822–827. doi:10.2460/ajvr.76.9.822
   PubMed Web of Science ®Google Scholar
• Franklin SP, Birdwhistell KE, Strelchik A, Garner BC, Brainard BM. Influence of cellular composition and exogenous activation on growth factor and cytokine concentrations in canine platelet-rich plasmas. Front Vet Sci. 2017;4:40. doi:10.3389/fvets.2017.00040
   PubMed Web of Science ®Google Scholar
• Carr BJ, Canapp JSO, Mason DR, Cox C, Hess T. Canine platelet-rich plasma systems: a prospective analysis. Front Vet Sci. 2016;2:73. doi:10.3389/fvets.2015.00073
   PubMedGoogle Scholar
• King W, Toler K, Woodell-May J. Role of white blood cells in blood-and bone marrow-based autologous therapies. BioMed Res Int. 2018;2018:1–8. doi:10.1155/2018/6510842
   Web of Science ®Google Scholar
• McCarrel TM, Minas T, Fortier LA. Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy. JBJS. 2012;94(19):e143. doi:10.2106/JBJS.L.00019
   Google Scholar
• Cavallo C, Filardo G, Mariani E, et al. Comparison of platelet-rich plasma formulations for cartilage healing: an in vitro study. JBJS. 2014;96(5):423–429. doi:10.2106/JBJS.M.00726
   PubMedGoogle Scholar
• Anitua E, Zalduendo M, Troya M, Padilla S, Orive G. Leukocyte inclusion within a platelet rich plasma-derived fibrin scaffold stimulates a more pro-inflammatory environment and alters fibrin properties. PLoS One. 2015;10(3):e0121713. doi:10.1371/journal.pone.0121713
   PubMed Web of Science ®Google Scholar
• Browning SR, Weiser AM, Woolf N, et al. Platelet-rich plasma increases matrix metalloproteinases in cultures of human synovial fibroblasts. JBJS. 2012;94(23):e172. doi:10.2106/JBJS.K.01501
   Google Scholar
• Sundman EA, Cole BJ, Fortier LA. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med. 2011;39(10):2135–2140. doi:10.1177/0363546511417792
   PubMed Web of Science ®Google Scholar
• van Drumpt RA, van der Weegen W, King W, Toler K, Macenski MM. Safety and treatment effectiveness of a single autologous protein solution injection in patients with knee osteoarthritis. BioRes Open Access. 2016;5(1):261–268. doi:10.1089/biores.2016.0014
   PubMedGoogle Scholar
• Hix J, Klaassen M, Foreman R, et al. An autologous anti-inflammatory protein solution yielded a favorable safety profile and significant pain relief in an open-label pilot study of patients with osteoarthritis. BioRes Open Access. 2017;6(1):151–158. doi:10.1089/biores.2017.0027
   PubMed Web of Science ®Google Scholar
• Kon E, Engebretsen L, Verdonk P, Nehrer S, Filardo G. Clinical outcomes of knee osteoarthritis treated with an autologous protein solution injection: a 1-year Pilot Double-Blinded Randomized Controlled Trial. Am J Sports Med. 2018;46(1):171–180. doi:10.1177/0363546517732734
   PubMed Web of Science ®Google Scholar
• Bertone AL, Ishihara A, Zekas LJ, et al. Evaluation of a single intra-articular injection of autologous protein solution for treatment of osteoarthritis in horses. Am J Vet Res. 2014;75(2):141–151. doi:10.2460/ajvr.75.2.141
   PubMed Web of Science ®Google Scholar
• Franklin SP. Pilot study assessing treatment of canine hip dysplasia using autologous protein solution. Front Vet Sci. 2019;In Submission:1–9.
   Google Scholar
• King W, van der Weegen W, Van Drumpt R, Soons H, Toler K, Woodell-May J. White blood cell concentration correlates with increased concentrations of IL-1ra and improvement in WOMAC pain scores in an open-label safety study of autologous protein solution. J Exp Orthop. 2016;3(1):9. doi:10.1186/s40634-016-0043-7
   PubMedGoogle Scholar
• King W, Steckbeck K, O’shaughnessey K, Woodell-May J Effect of preparation technique on anti-inflammatory properties of autologous therapies. Orthopedic Research Society Annual Meeting; 2015.
   Google Scholar
• Lorenz HP, Longaker MT. Wounds: biology, pathology, and management. In: Norton J, Bollinger RR, Chang AE, et al, Eds. Essential Practice of Surgery Basic Science and Clinical Evidence. New York, NY: Springer; 2003:77–88.
   Google Scholar
• Cassano JM, Kennedy JG, Ross KA, Fraser EJ, Goodale MB, Fortier LA. Bone marrow concentrate and platelet-rich plasma differ in cell distribution and interleukin 1 receptor antagonist protein concentration. Knee Surg Sports Traumatol Arthrosc. 2018;26(1):333–342. doi:10.1007/s00167-016-3981-9
   PubMed Web of Science ®Google Scholar
• Marques-Smith P, Kallerud AS, Johansen GM, et al. Is clinical effect of autologous conditioned serum in spontaneously occurring equine articular lameness related to ACS cytokine profile? BMC Vet Res. 2020;16:1–9. doi:10.1186/s12917-020-02391-7
   PubMed Web of Science ®Google Scholar
• Chahla J, Cinque ME, Piuzzi NS, et al. A call for standardization in platelet-rich plasma preparation protocols and composition reporting: a systematic review of the clinical orthopaedic literature. J Bone Joint Surg Am. 2017;99(20):1769–1779. doi:10.2106/JBJS.16.01374
   PubMed Web of Science ®Google Scholar
• Franklin SP, Burke EE, Holmes SP. The effect of platelet-rich plasma on osseous healing in dogs undergoing high tibial osteotomy. PLoS One. 2017;12(5):e0177597. doi:10.1371/journal.pone.0177597
   PubMed Web of Science ®Google Scholar
• Souza TF, Andrade AL, Ferrreira G, et al. Healing and expression of growth factors (TGF-β and PDGF) in canine radial ostectomy gap containing platelet-rich plasma. Vet Comp Orthop Traumatol. 2012;25(06):445–452. doi:10.3415/VCOT-10-10-0146
   PubMedGoogle Scholar
• Murray MM, Spindler KP, Devin C, et al. Use of a collagen-platelet rich plasma scaffold to stimulate healing of a central defect in the canine ACL. J Orthop Res. 2006;24(4):820–830. doi:10.1002/jor.20073
   PubMed Web of Science ®Google Scholar
• Franklin SP, Stoker AM, Bozynski CC, et al. Comparison of platelet-rich plasma, stromal vascular fraction (SVF), or SVF with an injectable PLGA nanofiber scaffold for the treatment of osteochondral injury in dogs. J Knee Surg. 2018;31(07):686–697.
   PubMedGoogle Scholar
• Pashuck TD, Kuroki K, Cook CR, Stoker AM, Cook JL. Hyaluronic acid versus saline intra-articular injections for amelioration of chronic knee osteoarthritis: a canine model. J Orthop Res. 2016;34(10):1772–1779. doi:10.1002/jor.23191
   PubMed Web of Science ®Google Scholar
• Cook JL, Smith PA, Bozynski CC, et al. Multiple injections of leukoreduced platelet rich plasma reduce pain and functional impairment in a canine model of ACL and meniscal deficiency. J Orthop Res. 2016;34(4):607–615. doi:10.1002/jor.23054
   PubMed Web of Science ®Google Scholar
• Goldring SR, Goldring MB. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res. 2004;427(Suppl):S27–S36. doi:10.1097/01.blo.0000144854.66565.8f
   Web of Science ®Google Scholar
• Goldring MB. The role of the chondrocyte in osteoarthritis. J Arthritis Rheumatism. 2000;43(9):1916–1926. doi:10.1002/1529-0131(200009)43:9<1916::AID-ANR2>3.0.CO;2-I
   PubMed Web of Science ®Google Scholar
• King W, Bendele A, Marohl T, Woodell-May J. Human blood-based anti-inflammatory solution inhibits osteoarthritis progression in a meniscal-tear rat study. J Orthop Res. 2017;35(10):2260–2268. doi:10.1002/jor.23528
   PubMed Web of Science ®Google Scholar
• Fossum TW, Duprey LP, Hedlund CS, Duncan L. Small Animal Surgery; Mosby; 1997.
   Google Scholar
• KuKanich B, Bidgood T, Knesl O. Clinical pharmacology of nonsteroidal anti-inflammatory drugs in dogs. Vet Anaesth Analg. 2012;39(1):69–90. doi:10.1111/j.1467-2995.2011.00675.x
   PubMed Web of Science ®Google Scholar
• Innes JF, Clayton J, Lascelles BDX. Review of the safety and efficacy of long-term NSAID use in the treatment of canine osteoarthritis. Vet Rec. 2010;166(8):226–230. doi:10.1136/vr.c97
   PubMed Web of Science ®Google Scholar
• Bell A, Helm J, Reid J. Veterinarians’ attitudes to chronic pain in dogs. Vet Rec. 2014;175(17):428. doi:10.1136/vr.102352
   PubMed Web of Science ®Google Scholar
• Belshaw Z, Asher L, Dean RS. The attitudes of owners and veterinary professionals in the United Kingdom to the risk of adverse events associated with using non-steroidal anti-inflammatory drugs (NSAIDs) to treat dogs with osteoarthritis. Prev Vet Med. 2016;131:121–126. doi:10.1016/j.prevetmed.2016.07.017
   PubMed Web of Science ®Google Scholar
• Zoetis I. Rimadyl chewable tablets: compliance unleashed; 2013. Available from: https://cupdf.com/document/rimadyl-unleashed.html. Accessed 4 May 2018.
   Google Scholar
• Thombre AG. Oral delivery of medications to companion animals: palatability considerations. Adv Drug Deliv Rev. 2004;56(10):1399–1413. doi:10.1016/j.addr.2004.02.012
   PubMed Web of Science ®Google Scholar
• Ehrenfest DMD, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte-and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009;27(3):158–167. doi:10.1016/j.tibtech.2008.11.009
   PubMed Web of Science ®Google Scholar
• DeLong JM, Russell RP, Mazzocca AD. Platelet-rich plasma: the PAW classification system. Arthroscopy. 2012;28(7):998–1009. doi:10.1016/j.arthro.2012.04.148
   PubMed Web of Science ®Google Scholar
• Rossi L, Murray I, Chu C, Muschler G, Rodeo S, Piuzzi N. Classification systems for platelet-rich plasma. Bone Joint J. 2019;101(8):891–896. doi:10.1302/0301-620X.101B8.BJJ-2019-0037.R1
   PubMedGoogle Scholar
• McClain AK, McCarrel TM. The effect of four different freezing conditions and time in frozen storage on the concentration of commonly measured growth factors and enzymes in equine platelet-rich plasma over six months. BMC Vet Res. 2019;15(1):1–9. doi:10.1186/s12917-019-2040-4
   PubMed Web of Science ®Google Scholar
• Anz AW, Parsa RS, Romero-Creel MF, et al. Exercise-mobilized platelet-rich plasma: short-term exercise increases stem cell and platelet concentrations in platelet-rich plasma. Arthroscopy. 2019;35(1):192–200. doi:10.1016/j.arthro.2018.06.043
   PubMed Web of Science ®Google Scholar
• Mannava S, Whitney KE, Kennedy MI, et al. The influence of naproxen on biological factors in leukocyte-rich platelet-rich plasma: a prospective comparative study. Arthroscopy. 2019;35(1):201–210. doi:10.1016/j.arthro.2018.07.030
   PubMed Web of Science ®Google Scholar
• Hessel L, Bosch G, Van Weeren P, Ionita JC. Equine autologous platelet concentrates: a comparative study between different available systems. Equine Vet J. 2015;47(3):319–325. doi:10.1111/evj.12288
   PubMed Web of Science ®Google Scholar
• Muir SM, Reisbig N, Baria M, Kaeding C, Bertone AL. The concentration of plasma provides additional bioactive proteins in platelet and autologous protein solutions. Am J Sports Med. 2019;47(8):1955–1963. doi:10.1177/0363546519849671
   PubMed Web of Science ®Google Scholar
• Tversky A, Kahneman D. Belief in the law of small numbers. Psychol Bull. 1971;76(2):105. doi:10.1037/h0031322
   Google Scholar
• Pietrzak WS, Eppley BL. Platelet rich plasma: biology and new technology. J Craniofac Surg. 2005;16(6):1043–1054. doi:10.1097/01.scs.0000186454.07097.bf
   PubMed Web of Science ®Google Scholar
• Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2004;91(01):4–15. doi:10.1160/TH03-07-0440
   PubMedGoogle Scholar
• Zhang J, Middleton KK, Fu FH, Im HJ, Wang JH. HGF mediates the anti-inflammatory effects of PRP on injured tendons. PLoS One. 2013;8(6):e67303. doi:10.1371/journal.pone.0067303
   PubMed Web of Science ®Google Scholar
• Matsui M, Tabata Y. Enhanced angiogenesis by multiple release of platelet-rich plasma contents and basic fibroblast growth factor from gelatin hydrogels. Acta Biomater. 2012;8(5):1792–1801. doi:10.1016/j.actbio.2012.01.016
   PubMed Web of Science ®Google Scholar